NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities
- 1 February 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (3), 1428-1436
- https://doi.org/10.1182/blood-2007-07-101311
Abstract
This study exploited alloreactivity of natural killer (NK) cells for augmenting the recognition of human acute myeloid leukemia (AML). To circumvent the inhibitory effect of killer immunoglobulin receptor (KIR) signaling, we generated NK-cell lines with single KIR specificities for major human leukocyte antigen (HLA) class I allotypes. We demonstrated efficient cytolysis of KIR-HLA class I–mismatched primary AML blasts even at low effector-to-target ratios. To define the impact of tumor-associated activating NKG2D-ligands (NKG2D-L), 66 AML patients at diagnosis were analyzed. NKG2D-L were selectively expressed on monoblastic cells in AML M4 and M5 yet absent or weakly expressed on myeloblastic cells in all AML subtypes. Paucity of cell-surface NKG2D-L was not the result of shedding because levels of soluble ULBP1 ligand measured in AML plasma were in the normal range. Notably, purified NKG2D-L+ monoblastic cells were more susceptible to NK-mediated killing than NKG2D-L− myeloblastic cells. Accordingly, induction of cell-surface NKG2D-L by treatment with the histone deacetylase inhibitor, valproic acid, rendered cells more sensitive to NK cytolysis. These data suggest that adoptive transfer of selected populations of alloreactive HLA class I–mismatched NK cells in combination with pharmacologic induction of NKG2D-L merits clinical evaluation as novel approaches to immunotherapy of human AML.Keywords
This publication has 55 references indexed in Scilit:
- A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immatureBlood, 2007
- Prospects for the use of NK cells in immunotherapy of human cancerNature Reviews Immunology, 2007
- Taking license with natural killer cell maturation and repertoire developmentImmunological Reviews, 2006
- The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantationTransplant Immunology, 2005
- Reconstitution of dendritic and natural killer–cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligandBlood, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- NK cells: a lesson from mismatched hematopoietic transplantationTrends in Immunology, 2002
- Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumorin vivoProceedings of the National Academy of Sciences, 2001
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- On guard—activating NK cell receptorsNature Immunology, 2001